EUVIMEDEUVIMED entdecken
Crossref

FLNA expression modulates pathological markers of pituitary neuroendocrine tumours

Jonathan Toledo, Pablo Aníbal Perez iD, Mical Zanetti, Graciela Díaz-Torga iD, Jorge Humberto Mukdsi, Silvina Gutierrez iD

Journal of Endocrinology · 2023

DOI: 10.1530/joe-23-0209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, 2023. Verfasst von Jonathan Toledo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones en Ciencias de la Salud (INICSA-CONICET), Córdoba, Argentina. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Neuroendocrine Tumors, Adenoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the current limited knowledge about the role of filamin A (FLNA) in pituitary tumour progression, we aimed to analyse FLNA expression levels and its impact on aggressive markers of pituitary neuroendocrine tumours (PitNETs), using an integrative approach of in vivo and in vitro models and human samples. An increase in the expression levels of FLNA was observed in the advanced tumoural stages of the hyperplastic adenomatous pituitary model, concomitant with a decrease in cell proliferation and with a modification in the subcellular localisation of this protein. Similarly, overexpression of FLNA in the somatolactotropic GH3 cell line induced a decrease in the cell proliferation, promoted a migratory phenotype, increased invasion activity, and decreased the prolactin secretion. Cyclin D1 (CCND1) and cyclin-dependent kinase 4 (CDK4) expression increased in both models in correlation with the increase observed in FLNA levels. When human tissues were analysed a significant increase of FLNA was observed in PitNETs compared to normal pituitary gland, with heterogeneous intracellular localisation. Higher levels of FLNA expression were observed in tumours with invasive characteristics. These results underline the crucial roles of FLNA as a modulator of pathological markers and as a potential prognostic marker in pituitary tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsNeuroendocrine TumorsAdenomaHumansFilaminsPituitary Gland

Stichwörter der Autor:innen

PitNETscyclin D1filamin Ainvasionpituitary adenomaprolactinproliferation

Substanzen

FilaminsFLNA protein, human

Autor:innen und Institutionen

  • Instituto de Investigaciones en Ciencias de la Salud (INICSA-CONICET), Córdoba, Argentina.
  • Centro de Microscopia Electrónica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
  • Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.

ORCID-Profile: Pablo Aníbal Perez, Graciela Díaz-Torga, Silvina Gutierrez

Zitieren

APA

Toledo, J., Perez, P. A., Zanetti, M., Díaz-Torga, G., Mukdsi, J. H., & Gutierrez, S. (2023). FLNA expression modulates pathological markers of pituitary neuroendocrine tumours. Journal of Endocrinology. https://doi.org/10.1530/joe-23-0209

Vancouver

Toledo J, Perez PA, Zanetti M, Díaz-Torga G, Mukdsi JH, Gutierrez S. FLNA expression modulates pathological markers of pituitary neuroendocrine tumours. Journal of Endocrinology. 2023. doi:10.1530/joe-23-0209

BibTeX
@article{Toledo2023,
  author = {Toledo, Jonathan and Perez, Pablo Aníbal and Zanetti, Mical and Díaz-Torga, Graciela and Mukdsi, Jorge Humberto and Gutierrez, Silvina},
  title = {FLNA expression modulates pathological markers of pituitary neuroendocrine tumours},
  journal = {Journal of Endocrinology},
  year = {2023},
  doi = {10.1530/joe-23-0209}
}
Kostenlos starten →